FMCQF OTC
Fresenius Medical Care AG
1W: +0.0%
1M: -13.3%
3M: -0.0%
YTD: -4.2%
1Y: -13.1%
3Y: +9.2%
5Y: -30.9%
$44.58
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$31.0B
-7.7% ▼
5Y CAGR: -0.4%
Total Liabilities
$16.7B
-6.1% ▼
5Y CAGR: -2.9%
Shareholders Equity
$13.3B
-8.7% ▼
5Y CAGR: +1.5%
Cash & Investments
$1.7B
+19.3% ▲
5Y CAGR: +6.8%
Total Debt
$13.7B
+24.8% ▲
5Y CAGR: +2.0%
Net Debt
$12.1B
+23.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.5B | $1.3B | $1.4B | $1.2B | $1.6B |
| Short-Term Investments | $136M | $170M | $136M | $296M | $127M |
| Cash & ST Investments | $1.6B | $1.4B | $1.5B | $1.4B | $1.7B |
| Net Receivables | $3.6B | $3.7B | $3.6B | $3.9B | $3.1B |
| Inventory | $2.0B | $2.3B | $2.2B | $2.1B | $2.1B |
| Other Current Assets | $346M | $378M | $1.3B | $432M | $888M |
| Total Current Assets | $8.0B | $8.2B | $8.7B | $7.9B | $7.9B |
| Property, Plant & Equip. | $4.3B | $4.2B | $7.5B | $7.3B | $3.0B |
| Goodwill & Intangibles | $15.8B | $17.3B | $16.0B | $16.5B | $14.8B |
| Long-Term Investments | $787M | $774M | $1.3B | $1.4B | $1.5B |
| Other Non-Current Assets | $5.2B | $5.0B | $224M | $198M | $3.8B |
| Total Non-Current Assets | $26.4B | $27.6B | $25.2B | $25.6B | $23.1B |
| Total Assets | $34.4B | $35.8B | $33.9B | $33.6B | $31.0B |
| — Liabilities — | |||||
| Accounts Payable | $858M | $952M | $762M | $984M | $738M |
| Short-Term Debt | $1.9B | $1.4B | $945M | $577M | $2.2B |
| Deferred Revenue | $518M | $106M | $86M | $82M | $0 |
| Other Current Liabilities | $2.2B | $2.3B | $3.0B | $2.8B | $3.3B |
| Total Current Liabilities | $7.3B | $6.5B | $6.1B | $5.7B | $6.2B |
| Long-Term Debt | $6.6B | $7.2B | $7.0B | $6.3B | $8.6B |
| Other Non-Current Liab. | $1.5B | $1.7B | $1.7B | $1.6B | -$1.7B |
| Total Non-Current Liabilities | $13.1B | $13.8B | $13.0B | $12.1B | $10.5B |
| Total Liabilities | $20.4B | $20.3B | $19.1B | $17.8B | $16.7B |
| — Equity — | |||||
| Common Stock | $293M | $293M | $293M | $293M | $293M |
| Retained Earnings | $10.8B | $10.7B | $10.9B | $11.3B | $12.2B |
| Accumulated OCI | -$1.3B | -$388M | -$975M | -$329M | -$1.7B |
| Total Stockholders Equity | $14.0B | $15.4B | $13.6B | $14.6B | $13.3B |
| Total Liabilities & Equity | $34.4B | $35.8B | $33.9B | $33.6B | $31.0B |
| — Key Metrics — | |||||
| Total Debt | $13.3B | $13.2B | $12.1B | $11.0B | $13.7B |
| Net Debt | $11.8B | $11.9B | $10.7B | $9.8B | $12.1B |
| Total Investments | $923M | $944M | $1.4B | $1.7B | $1.6B |